Literature DB >> 26682921

Cardiac Rehabilitation Program Adherence and Functional Capacity Among Women: A Randomized Controlled Trial.

Sherry L Grace1, Liz Midence2, Paul Oh3, Stephanie Brister3, Caroline Chessex3, Donna E Stewart3, Heather M Arthur4.   

Abstract

OBJECTIVE: To compare program adherence and functional capacity between women referred to supervised mixed-sex, supervised women-only, or home-based cardiac rehabilitation (CR). PATIENTS AND METHODS: Cardiac Rehabilitation for Heart Event Recovery (CR4HER) was a single-blind, 3 parallel-arm, pragmatic randomized controlled trial. The study took place between November 1, 2009, and July 31, 2013. Low-risk patients with coronary artery disease were recruited from 6 hospitals in Ontario, Canada. Consenting participants completed a preprogram survey, and clinical data were extracted from charts. Participants were referred to CR at 1 of 3 sites. After intake assessment, including a graded exercise stress test, eligible patients were randomized to supervised mixed-sex, supervised women-only, or home-based CR. Six months later, CR adherence and exit assessment data were ascertained.
RESULTS: Of the 264 consenting patients, 169 (64.0%) were eligible and randomized. Twenty-seven (16.0%) did not attend, and 43 (25.4%) attended a different model. Program adherence was moderate overall (54.46%±35.14%). Analysis of variance revealed no significant differences based on per-protocol analysis (P=.63), but as-treated, home-based participants attended significantly more than did women-only participants (P<.05). Overall, there was a significant increase in functional capacity preprogram to postprogram (P<.001). Although there were no significant differences in functional capacity by model at CR exit based on per-protocol analysis, there was a significant difference on an as-treated basis, which sustained adjustment. Women attending mixed-sex CR attained significantly higher post-CR functional capacity than did women attending home-based programs (P<.05).
CONCLUSION: Offering women alternative program models may not promote greater CR adherence or functional capacity; however, replication is warranted. Other proven strategies such as action planning and self-monitoring should be applied. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01019135.
Copyright © 2016 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26682921     DOI: 10.1016/j.mayocp.2015.10.021

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

Review 1.  Cardiac Rehabilitation Following Acute Coronary Syndrome in Women.

Authors:  Amanda L Bennett; Carl J Lavie; Sherry L Grace
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-08

Review 2.  Cardiac Rehabilitation for Women: A Systematic Review of Barriers and Solutions.

Authors:  Marta Supervía; Jose R Medina-Inojosa; Colin Yeung; Francisco Lopez-Jimenez; Ray W Squires; Carmen M Pérez-Terzic; LaPrincess C Brewer; Shawn E Leth; Randal J Thomas
Journal:  Mayo Clin Proc       Date:  2017-03-13       Impact factor: 7.616

3.  Disparities in Cardiac Rehabilitation Among Individuals from Racial and Ethnic Groups and Rural Communities-A Systematic Review.

Authors:  Luis R Castellanos; Omar Viramontes; Nainjot K Bains; Ignacio A Zepeda
Journal:  J Racial Ethn Health Disparities       Date:  2018-03-13

4.  Home-Based Cardiac Rehabilitation: A SCIENTIFIC STATEMENT FROM THE AMERICAN ASSOCIATION OF CARDIOVASCULAR AND PULMONARY REHABILITATION, THE AMERICAN HEART ASSOCIATION, AND THE AMERICAN COLLEGE OF CARDIOLOGY.

Authors:  Randal J Thomas; Alexis L Beatty; Theresa M Beckie; LaPrincess C Brewer; Todd M Brown; Daniel E Forman; Barry A Franklin; Steven J Keteyian; Dalane W Kitzman; Judith G Regensteiner; Bonnie K Sanderson; Mary A Whooley
Journal:  J Cardiopulm Rehabil Prev       Date:  2019-07       Impact factor: 2.081

Review 5.  Improving Medication Adherence in Cardiometabolic Disease: Practical and Regulatory Implications.

Authors:  Keith C Ferdinand; Fortunato Fred Senatore; Helene Clayton-Jeter; Dennis R Cryer; John C Lewin; Samar A Nasser; Mona Fiuzat; Robert M Califf
Journal:  J Am Coll Cardiol       Date:  2017-01-31       Impact factor: 24.094

Review 6.  Cardiac Rehabilitation: Under-Utilized Globally.

Authors:  Sherry L Grace; Kornelia Kotseva; Mary A Whooley
Journal:  Curr Cardiol Rep       Date:  2021-07-16       Impact factor: 2.931

7.  Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology.

Authors:  Randal J Thomas; Alexis L Beatty; Theresa M Beckie; LaPrincess C Brewer; Todd M Brown; Daniel E Forman; Barry A Franklin; Steven J Keteyian; Dalane W Kitzman; Judith G Regensteiner; Bonnie K Sanderson; Mary A Whooley
Journal:  J Am Coll Cardiol       Date:  2019-05-13       Impact factor: 24.094

8.  Clinical Practice Guideline for Cardiac Rehabilitation in Korea.

Authors:  Chul Kim; Jidong Sung; Jong Hwa Lee; Won-Seok Kim; Goo Joo Lee; Sungju Jee; Il-Young Jung; Ueon Woo Rah; Byung Ok Kim; Kyoung Hyo Choi; Bum Sun Kwon; Seung Don Yoo; Heui Je Bang; Hyung-Ik Shin; Yong Wook Kim; Heeyoune Jung; Eung Ju Kim; Jung Hwan Lee; In Hyun Jung; Jae-Seung Jung; Jong-Young Lee; Jae-Young Han; Eun Young Han; Yu Hui Won; Woosik Han; Sora Baek; Kyung-Lim Joa; Sook Joung Lee; Ae Ryoung Kim; So Young Lee; Jihee Kim; Hee Eun Choi; Byeong-Ju Lee; Soon Kim
Journal:  Ann Rehabil Med       Date:  2019-06-28

Review 9.  Home-based versus centre-based cardiac rehabilitation.

Authors:  Lindsey Anderson; Georgina A Sharp; Rebecca J Norton; Hasnain Dalal; Sarah G Dean; Kate Jolly; Aynsley Cowie; Anna Zawada; Rod S Taylor
Journal:  Cochrane Database Syst Rev       Date:  2017-06-30

Review 10.  Underutilization of Cardiac Rehabilitation in Women: BARRIERS AND SOLUTIONS.

Authors:  Sherrie Khadanga; Diann E Gaalema; Patrick Savage; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-07-01       Impact factor: 3.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.